Hematopoietic Stem Cell TransplantationTransplantation, HomologousRegistriesStem Cell TransplantationFetal BloodGraft vs Host DiseaseTransplantation ConditioningUmbilical CordCord Blood Stem Cell TransplantationTissue DonorsHematologic NeoplasmsTransplantation, AutologousPeripheral Blood Stem Cell TransplantationStem CellsTransplantation ChimeraHematopoietic Stem CellsHistocompatibility TestingMyeloablative AgonistsBone Marrow TransplantationTreatment OutcomeGraft vs Leukemia EffectBusulfanVidarabineRecurrenceGraft SurvivalRemission InductionAntigens, CD34Graft vs Tumor EffectLeukemiaHematopoietic Stem Cell MobilizationLeukemia, Myeloid, AcuteRetrospective StudiesImmunosuppressive AgentsLymphocyte TransfusionSiblingsDonor SelectionWhole-Body IrradiationBlood BanksMultiple MyelomaCytomegalovirus InfectionsLeukemia, Myelogenous, Chronic, BCR-ABL PositiveT-LymphocytesHistocompatibilityTime FactorsDisease-Free SurvivalCombined Modality TherapySurvival AnalysisMinor Histocompatibility AntigensAntilymphocyte SerumSurvival RateCells, CulturedLiver TransplantationChimerismSalvage TherapyMyelodysplastic SyndromesPrecursor Cell Lymphoblastic Leukemia-LymphomaLymphocyte DepletionVirus ActivationGranulocyte Colony-Stimulating FactorNeoplasm, ResidualCell DifferentiationUmbilical VeinsMesenchymal Stem Cell TransplantationHLA AntigensAnemia, AplasticHematologic DiseasesBone Marrow CellsMelphalanInfant, NewbornCytomegalovirusBlood DonorsHepatic Veno-Occlusive DiseaseUmbilical ArteriesFlow CytometryAcute DiseaseCell TransplantationFollow-Up StudiesCyclophosphamideAntineoplastic Combined Chemotherapy ProtocolsMesenchymal Stromal CellsHematopoiesisLiving DonorsEmbryonic Stem CellsKidney TransplantationPregnancyPrimary MyelofibrosisAntigens, CDPrognosisCell SeparationImmunophenotypingTransplantation ImmunologyLeukemia, Myeloid, Accelerated PhaseRoseolovirus InfectionsLeukemia, MyeloidImmunosuppressionLymphocytesFusion Proteins, bcr-ablBenzamidesAntibodies, NeoplasmCell Lineage